Civil Actions To Obtain Patent Certainty: Controversy At The Federal Circuit - News, Articles, and Events

Civil Actions To Obtain Patent Certainty: Controversy At The Federal Circuit

Mark E. Waddell

June 2008 | The Metropolitan Corporate Counsel

Click here to download the full article.

This article explores the long-standing controversy over the proper role for the courts in resolving business disputes affecting generic drug competition. The disputes are grounded in some interesting, albeit perplexing, discussions of basic issues involving jurisdiction.

Mark E. Waddell is a partner and co-chair of the patent litigation practice group in the New York office of Loeb & Loeb LLP and can be reached at .

This article was first printed in the June 2008 edition of The Metropolitan Corporate Counsel. Permission for article reprint has been granted.

This Web site may constitute "Attorney Advertising" under the New York Rules of Professional Conduct and under the law of other jurisdictions.
Your use of our Web site or its facilities constitutes your acceptance of the Terms of Use and Privacy Policy, which are accessible in the link at the bottom left of this page.